Because of the close interaction of COX-2 and PPARγ, the differential expression in many human tumors, and the emerging possibilities to use them as targets for tumor therapy, we studied the correlation of PPARγ/COX-2 immunoreactivity with tissue microarrays (TMA) in a broad spectrum of histologic tumor types in comparison to normal tissue. This evidence concerns the gene PPARG and neoplasm.